Welcome
Summary

 Principal Investigators (Canada)

 Dr. Niall Ferguson 
  

 
Dr. Fran├žois Lamontagne

 
 

 Principal Investigators (USA)
 Dr. Derek C. Angus
 Dr. Marc Moss

Thanks to the CCCTG and the PETAL Network endorsing this research project.

NIH Review Committee

Feb. 2015: The ROSE trial was approved by the NIH Protocol Review Committee and will enrol patients beginning in 2016.


Feb 2015:  International Experts Endorse the Importance of Studying NMB in ARDS. The Steering Committee of the US NHLBI PETAL Network - funded to study the prevention and early treatment of ARDS - has voted unanimously to conduct a RCT of NMB vs usual care in moderate-severe ARDS as one of the first PETAL Network Trials. The ROSE trial was subsequently approved by the NIH Protocol Review Committee and will enrol patients beginning in 2016.
25 February 2016